Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

Eleftherios Mylonakis; Joseph Lutaakome; Mamta K. Jain; Angela J. Rogers; José Moltó; Susana Benet; Ahmad Mourad; D. Clark Files; Henry Mugerwa; Cissy Kityo; Francis Kiweewa; Mary Grace Nalubega; Jonathan Kitonsa; Evelyn Nabenkema; Daniel D. Murray; Dominique Braun; Dena Kamel; Elizabeth S. Higgs; Timothy J. Hatlen; Virginia L. Kan; Adriana Sanchez; John Tierney; Eileen Denner; Deborah Wentworth; Abdel G. Babiker; Victoria J. Davey; Annetine C. Gelijns; Gail V. Matthews; B. Taylor Thompson; H. Clifford Lane; James D. Neaton; Jens D. Lundgren

doi:10.1016/j.medj.2022.07.003

Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

Eleftherios Mylonakis, Joseph Lutaakome, Mamta K. Jain, Angela J. Rogers, José Moltó, Susana Benet, Ahmad Mourad, D. Clark Files, Henry Mugerwa, Cissy Kityo, Francis Kiweewa, Mary Grace Nalubega, Jonathan Kitonsa, Evelyn Nabenkema, Daniel D. Murray, Dominique Braun, Dena Kamel, Elizabeth S. Higgs, Timothy J. Hatlen, Virginia L. KanAdriana Sanchez, John Tierney, Eileen Denner, Deborah Wentworth, Abdel G. Babiker, Victoria J. Davey, Annetine C. Gelijns, Gail V. Matthews, B. Taylor Thompson, H. Clifford Lane, James D. Neaton, Jens D. Lundgren

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.

Original language	English (US)
Pages (from-to)	531-537
Number of pages	7
Journal	Med
Volume	3
Issue number	8
DOIs	https://doi.org/10.1016/j.medj.2022.07.003
State	Published - Aug 12 2022
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.medj.2022.07.003

Cite this

Mylonakis, E., Lutaakome, J., Jain, M. K., Rogers, A. J., Moltó, J., Benet, S., Mourad, A., Files, D. C., Mugerwa, H., Kityo, C., Kiweewa, F., Nalubega, M. G., Kitonsa, J., Nabenkema, E., Murray, D. D., Braun, D., Kamel, D., Higgs, E. S., Hatlen, T. J., ... Lundgren, J. D. (2022). Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO). Med, 3(8), 531-537. https://doi.org/10.1016/j.medj.2022.07.003

Mylonakis, E, Lutaakome, J, Jain, MK, Rogers, AJ, Moltó, J, Benet, S, Mourad, A, Files, DC, Mugerwa, H, Kityo, C, Kiweewa, F, Nalubega, MG, Kitonsa, J, Nabenkema, E, Murray, DD, Braun, D, Kamel, D, Higgs, ES, Hatlen, TJ, Kan, VL, Sanchez, A, Tierney, J, Denner, E, Wentworth, D, Babiker, AG, Davey, VJ, Gelijns, AC, Matthews, GV, Thompson, BT, Lane, HC, Neaton, JD & Lundgren, JD 2022, 'Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)', Med, vol. 3, no. 8, pp. 531-537. https://doi.org/10.1016/j.medj.2022.07.003

@article{eef3414ba5524384b4c94088652a128e,

title = "Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)",

abstract = "The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.",

author = "Eleftherios Mylonakis and Joseph Lutaakome and Jain, {Mamta K.} and Rogers, {Angela J.} and Jos{\'e} Molt{\'o} and Susana Benet and Ahmad Mourad and Files, {D. Clark} and Henry Mugerwa and Cissy Kityo and Francis Kiweewa and Nalubega, {Mary Grace} and Jonathan Kitonsa and Evelyn Nabenkema and Murray, {Daniel D.} and Dominique Braun and Dena Kamel and Higgs, {Elizabeth S.} and Hatlen, {Timothy J.} and Kan, {Virginia L.} and Adriana Sanchez and John Tierney and Eileen Denner and Deborah Wentworth and Babiker, {Abdel G.} and Davey, {Victoria J.} and Gelijns, {Annetine C.} and Matthews, {Gail V.} and Thompson, {B. Taylor} and Lane, {H. Clifford} and Neaton, {James D.} and Lundgren, {Jens D.}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = aug,

day = "12",

doi = "10.1016/j.medj.2022.07.003",

language = "English (US)",

volume = "3",

pages = "531--537",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "8",

}

TY - JOUR

T1 - Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

AU - Mylonakis, Eleftherios

AU - Lutaakome, Joseph

AU - Jain, Mamta K.

AU - Rogers, Angela J.

AU - Moltó, José

AU - Benet, Susana

AU - Mourad, Ahmad

AU - Files, D. Clark

AU - Mugerwa, Henry

AU - Kityo, Cissy

AU - Kiweewa, Francis

AU - Nalubega, Mary Grace

AU - Kitonsa, Jonathan

AU - Nabenkema, Evelyn

AU - Murray, Daniel D.

AU - Braun, Dominique

AU - Kamel, Dena

AU - Higgs, Elizabeth S.

AU - Hatlen, Timothy J.

AU - Kan, Virginia L.

AU - Sanchez, Adriana

AU - Tierney, John

AU - Denner, Eileen

AU - Wentworth, Deborah

AU - Babiker, Abdel G.

AU - Davey, Victoria J.

AU - Gelijns, Annetine C.

AU - Matthews, Gail V.

AU - Thompson, B. Taylor

AU - Lane, H. Clifford

AU - Neaton, James D.

AU - Lundgren, Jens D.

PY - 2022/8/12

Y1 - 2022/8/12

N2 - The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.

AB - The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.

UR - http://www.scopus.com/inward/record.url?scp=85135901219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85135901219&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2022.07.003

DO - 10.1016/j.medj.2022.07.003

M3 - Comment/debate

C2 - 35963234

AN - SCOPUS:85135901219

SN - 2666-6359

VL - 3

SP - 531

EP - 537

JO - Med

JF - Med

IS - 8

ER -

Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this